CD34 and neoplasm: The tumor cells exhibited an endothelial cell phenotype with diffuse strong positivity for CD34, CD31, ERG, and FLi-1 (Figures 3A–D), and diffuse and strong nuclear reactivity to TFE3 (Figure 3E).